On November 17,2022, the sub-center of the National Multicenter Registration Project for Hepatitis D Virus Infected Persons (CDiS) started to hold the kick-off meeting of the sub-center of Foshan Fourth People's Hospital in the form of "online+offline".
The director of China Liver Health, the appointed chairman of the Chinese Medical Association Liver Disease Credit Committee, and Professor Nan Yuemin of the Third Hospital of Hebei Medical University attended the meeting as a specially invited expert online. President Ye Yinong of the Fourth People's Hospital of Foshan City, Professor Gong Weijin of the Department of Infectious Diseases, department clinicians and research team attended the meeting.
Professor Nan Yuemin made an opening speech and introduced the background of the project. He warmly welcomed the Fourth People's Hospital of Foshan City to actively participate in the national multi-center hepatitis D virus infection registration project, and wished the project a smooth progress.
The CDiS project was initiated by the China Liver Health, called by Zhuang Hui, academician of Peking University Medical Department, and led by Professor Wei Lai of Tsinghua Changgeng Hospital in Beijing. The purpose of the project is to evaluate the annual cumulative incidence of disease progression and clinical outcomes of patients with hepatitis D virus (HDV) infection, and to provide scientific basis for further evaluation of the disease burden of HDV infection.
President Ye Yinong said in a speech that the prevention and treatment of infectious diseases is of great importance. At present, the epidemiological characteristics of hepatitis D in China are unclear, and screening diagnosis and disease diagnosis and treatment need to be improved. The implementation of CDiS project has far-reaching significance for the prevention and treatment of hepatitis D in China. I hope that the medical staff of the hospital will pay high attention to it and actively promote the CDiS project.
Director Gong Weijin explained the CDiS project in simple terms from the aspects of research background, research purpose, scheme design, inclusion criteria, follow-up plan, adverse event treatment, etc. in combination with his own experience. Aisha medical representative introduced the intelligent platform of hepatitis D and the process of blood sample collection and submission in detail.
During the discussion, Director Gong Weijin divided the staff according to the characteristics of the project and the situation of the hospital. Director Gong said that it was a great honor for Foshan Fourth People's Hospital to join CDiS as a sub-center. In the future, it will actively implement patient screening and other work to promote the inclusion of patients in the project.